Company: SHPH
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001493152-25-008300
Chunk: 1196

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-26
Form: 10-K
Item: Item 7A
Chunk 1196
---
 to develop and recommend to the board of directors
a set of corporate governance principles applicable to the Company, and to oversee the evaluation of the board of directors and the Company’s
management. In addition, the nominating and corporate governance committee will consider diversity of background including diversity
of race, ethnicity, international background, gender and age when evaluating candidates for board of directors membership.

Further,
the nominating and corporate governance committee, to the extent it deems necessary or appropriate, among its several other responsibilities
will:

    ●
    recommend
    to the board of directors and for approval by a majority of independent directors for election by stockholders or appointment by
    the board of directors as the case may be, pursuant to our bylaws and consistent with the board of director’s evidence for
    selecting new directors;

    ●
    review
    the suitability for continued service as a director of each member of the board of directors when his or her term expires or when
    he or she has a significant change in status;

    ●
    review
    annually the composition of the board of directors and to review periodically the size of the board of directors;

    ●
    make
    recommendations on the frequency and structure of board of directors meetings or any other aspect of procedures of the board of directors;

    ●
    make
    recommendations regarding the chairmanship and composition of standing committees and monitor their functions;

    ●
    review
    annually committee assignments and chairmanships;

    ●
    recommend
    the establishment of special committees as may be necessary or desirable from time to time; and

    ●
    develop
    and periodically review corporate governance procedures and consider any other corporate governance issue.

Code
of Ethics

We
have adopted a code of ethics that applies to all of our executive officers, directors and employees. The code of ethics codifies the
business and ethical principles that govern all aspects of our business. This document will be made available in print, free of charge,
to any stockholder requesting a copy in writing from our secretary at our executive offices in Gaithersburg, Maryland. A copy of our
code of ethics is available on our website at www.shuttlepharma.com.

77

Insider
Trading Policies and Procedures

The
Company has adopted an insider trading policy, as amended and restated on March 10, 2023 (the “Insider Trading Policy”),
overseen by the Company’s corporate secretary, that applies to all (i) directors